Current Technological Advancements on Erythropoietin Drugs Market SWOT Analysis & Technological Innovation by Leading Industry Experts
Download the Sample Report @ http://bit.ly/2L4eoGQ
Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% of the patients suffering from Cancer/HIV and ~70% of the patients suffering from ESRD undergo chemotherapy, which induces anemia in such patients, requiring EPO treatment. Despite this, the market nevertheless witnesses restraints due to highly priced EPO drugs resulting in minimal adoption. However, commercialization of EPO biosimilars would eventually ease the influence of restraints and fuel the market growth, primarily across the developing regions.
Globally, ~70% of the market share is held by the developed regions owing to favorable reimbursements leading to affordability for EPO drugs. Going forward, owing to commercialization of EPO biosimilars, the Asia-Pacific EPO drugs market would be the most potential market among other regions.
Key findings of the study:
• Europe led the global EPO drug market in 2013 closely followed by North America
• Asia Pacific EPO drugs market is projected to grow at a CAGR of 13.3% during the forecast period, fastest among the four geographies
• Currently, Anemia therapeutics (Cancer and HIV treatment) market leads the overall EPO drugs market; however, kidney therapeutic segment would emerge as the largest market segment by 2020
• Originator companies are investing in R&D for expanding product i.e. EPO drug applications to newer disorders such as neural diseases and in wound healing
• EPO drugs market is witnessing high commercialization of biosimilars for the 'off-patent' drug namely Erythropoietin alfa
For More Inquiry @ http://bit.ly/2WPE6Ry
The first EPO drug - Epogen (Erythropoietin alfa), launched by Amgen, has witnessed patent expiry in 2014. Following this, a number of biosimilar Erythropoietin alfa have been launched by major companies such as Biocon, Ranbaxy, Emcure Pharmaceuticals. In addition, Amgen currently owns the patent Aranesp for Darbepoetin alfa; which is expected to expire by 2016, thus, calling for launch of Darbepoetin alfa biosimilars.
Some of leading players operating in EPO drug market are Amgen Inc., Johnson & Johnson, Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Current Technological Advancements on Erythropoietin Drugs Market SWOT Analysis & Technological Innovation by Leading Industry Experts here
News-ID: 1783093 • Views: 547
More Releases from Allied Market Research
Retractable Awnings Market Growth, Regional Demand, Top Vendors and Segments by …
The Retractable Awnings Market have the ability to retract. It is the best solution to create a shade. Retractable awnings give protection from sunlight and rain. These awnings are easy to install and maintain. Retractable awnings extend the outdoor space area and reduce the cooling system cost. It also enhances the beauty of the outdoor space. It is an awning attached to a frame, which allows it to be extended
Fire Stopping Materials Market Size, Company Profiles, Opportunities and Forecas …
The Fire Stopping Materials Market is a passive fire protection system made up of different components that are used to seal joints and gaps in fire-resistant rated walls and floor assemblies. Sealing these joints is a technique that can be applied at every roof that meets a wall structure. Fire stopping materials have ability to prevent spreading of fire and smoke from one area to another. This means that the
Escalators Market Trends, Top Leading Companies, End Users and Forecast by 2030
The Escalators Market those ever-moving staircases that effortlessly transport people between different levels of buildings, have become an integral part of modern urban infrastructure. From bustling airports to shopping malls, these mechanical wonders have revolutionized vertical transportation, making it convenient and efficient. In this article, we will delve into the global escalators market, its growth drivers, key players, and the future trends shaping this industry. The global escalators market size was
Silver Nanoparticles Market Size and Projected Growth and Forecast 2030
Allied Market Research published a report, titled, "Silver Nanoparticles Market by Synthesis Method (Wet Chemistry, Ion Implantation, and Biological Synthesis), Shape (Spheres, Platelets, Rods, Colloidal Silver Particles, and Others), and Application (Healthcare & Lifescience, Textile, Electronics & IT, Food & Beverages, Pharmaceuticals, Cosmetics, Water Treatment, and Others): Global Opportunity Analysis and Industry Forecast 2021-2030." Market Statistics: The silver nanoparticle industry was valued at $1.5 billion in 2020, and is projected
More Releases for EPO
Global EPO Biomarkers Market Share: Trends, Key Players, Industry Analysis Repor …
The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfa
EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 20 …
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancer
EPO Biomarkers Market : Industry Research, Study, Growth Analysis Report 2019 & …
Researchmoz added Most up-to-date research on “Global EPO Biomarkers Market Size, Status and Forecast 2019-2025” to its huge collection of research reports. The EPO Biomarkers market report [6 Year Forecast 2019-2025] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin …
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in